Masimo Operating Margin 2010-2025 | MASI
Current and historical operating margin for Masimo (MASI) over the last 10 years. The current operating profit margin for Masimo as of March 31, 2025 is 16.17%.
| Masimo Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $2.13B | $-0.24B | -11.38% |
| 2024-12-31 | $2.10B | $-0.27B | -12.74% |
| 2024-09-30 | $1.89B | $0.16B | 8.20% |
| 2024-06-30 | $1.86B | $0.15B | 8.05% |
| 2024-03-31 | $1.82B | $0.15B | 8.28% |
| 2023-12-31 | $2.05B | $0.14B | 6.64% |
| 2023-09-30 | $2.12B | $0.17B | 7.80% |
| 2023-06-30 | $2.19B | $0.20B | 8.92% |
| 2023-03-31 | $2.30B | $0.19B | 8.19% |
| 2022-12-31 | $2.04B | $0.21B | 10.32% |
| 2022-09-30 | $1.75B | $0.21B | 12.26% |
| 2022-06-30 | $1.50B | $0.23B | 15.09% |
| 2022-03-31 | $1.24B | $0.27B | 21.70% |
| 2021-12-31 | $1.24B | $0.28B | 22.28% |
| 2021-09-30 | $1.21B | $0.26B | 21.89% |
| 2021-06-30 | $1.18B | $0.26B | 21.75% |
| 2021-03-31 | $1.17B | $0.25B | 21.57% |
| 2020-12-31 | $1.14B | $0.26B | 22.38% |
| 2020-09-30 | $1.10B | $0.25B | 23.06% |
| 2020-06-30 | $1.05B | $0.25B | 23.38% |
| 2020-03-31 | $0.98B | $0.24B | 24.05% |
| 2019-12-31 | $0.94B | $0.22B | 23.64% |
| 2019-09-30 | $0.91B | $0.21B | 23.41% |
| 2019-06-30 | $0.90B | $0.21B | 23.55% |
| 2019-03-31 | $0.88B | $0.21B | 24.03% |
| 2018-12-31 | $0.86B | $0.21B | 24.33% |
| 2018-09-30 | $0.84B | $0.20B | 23.70% |
| 2018-06-30 | $0.83B | $0.19B | 23.49% |
| 2018-03-31 | $0.81B | $0.19B | 23.08% |
| 2017-12-31 | $0.79B | $0.18B | 23.29% |
| 2017-09-30 | $0.78B | $0.47B | 59.39% |
| 2017-06-30 | $0.76B | $0.46B | 60.55% |
| 2017-03-31 | $0.74B | $0.45B | 61.03% |
| 2016-12-31 | $0.71B | $0.44B | 61.15% |
| 2016-09-30 | $0.68B | $0.15B | 21.65% |
| 2016-06-30 | $0.66B | $0.14B | 20.78% |
| 2016-03-31 | $0.65B | $0.13B | 20.09% |
| 2015-12-31 | $0.63B | $0.12B | 19.02% |
| 2015-09-30 | $0.63B | $0.12B | 18.53% |
| 2015-06-30 | $0.62B | $0.11B | 17.83% |
| 2015-03-31 | $0.60B | $0.10B | 16.61% |
| 2014-12-31 | $0.59B | $0.10B | 17.55% |
| 2014-09-30 | $0.57B | $0.08B | 14.64% |
| 2014-06-30 | $0.55B | $0.08B | 14.80% |
| 2014-03-31 | $0.55B | $0.09B | 15.82% |
| 2013-12-31 | $0.55B | $0.08B | 14.65% |
| 2013-09-30 | $0.54B | $0.09B | 16.60% |
| 2013-06-30 | $0.52B | $0.09B | 16.41% |
| 2013-03-31 | $0.51B | $0.09B | 16.86% |
| 2012-12-31 | $0.49B | $0.09B | 17.24% |
| 2012-09-30 | $0.47B | $0.08B | 17.55% |
| 2012-06-30 | $0.46B | $0.08B | 18.34% |
| 2012-03-31 | $0.45B | $0.08B | 18.65% |
| 2011-12-31 | $0.44B | $0.09B | 19.59% |
| 2011-09-30 | $0.43B | $0.09B | 20.32% |
| 2011-06-30 | $0.43B | $0.09B | 21.40% |
| 2011-03-31 | $0.42B | $0.09B | 21.67% |
| 2010-12-31 | $0.41B | $0.11B | 26.35% |
| 2010-09-30 | $0.39B | $0.11B | 26.97% |
| 2010-06-30 | $0.38B | $0.10B | 27.44% |
| 2010-03-31 | $0.36B | $0.10B | 28.37% |
| 2009-12-31 | $0.35B | $0.08B | 23.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.006B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $174.604B | 21.12 |
| Intuitive Surgical (ISRG) | United States | $169.147B | 70.11 |
| IDEXX Laboratories (IDXX) | United States | $52.172B | 54.30 |
| Edwards Lifesciences (EW) | United States | $45.888B | 30.41 |
| Alcon (ALC) | Switzerland | $41.768B | 28.23 |
| IQVIA Holdings (IQV) | United States | $30.615B | 17.30 |
| DexCom (DXCM) | United States | $30.529B | 45.79 |
| Mettler-Toledo (MTD) | United States | $25.882B | 30.72 |
| STERIS (STE) | Ireland | $23.797B | 25.33 |
| Waters (WAT) | United States | $16.625B | 22.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.421B | 0.00 |
| Hologic (HOLX) | United States | $15.122B | 16.38 |
| Penumbra (PEN) | United States | $9.340B | 68.23 |
| Sysmex ADR (SSMXY) | Japan | $8.668B | 27.54 |
| Globus Medical (GMED) | United States | $8.046B | 18.51 |
| Teleflex (TFX) | United States | $5.124B | 8.27 |
| Glaukos (GKOS) | United States | $4.991B | 0.00 |
| TransMedics (TMDX) | United States | $4.338B | 65.94 |
| Integer Holdings (ITGR) | United States | $3.693B | 18.43 |
| LivaNova (LIVN) | United Kingdom | $2.706B | 15.49 |
| Alphatec Holdings (ATEC) | United States | $2.267B | 0.00 |
| Veracyte (VCYT) | United States | $2.202B | 30.42 |
| PROCEPT BioRobotics (PRCT) | United States | $2.157B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Artivion (AORT) | United States | $2.027B | 102.29 |
| Elekta AB (EKTAY) | Sweden | $1.853B | 16.66 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.001B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.993B | 5.69 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.683B | 0.00 |
| SiBone (SIBN) | United States | $0.664B | 0.00 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.522B | 4.20 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.488B | 8.62 |
| OrthoPediatrics (KIDS) | United States | $0.472B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.404B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 87.58 |
| AngioDynamics (ANGO) | United States | $0.343B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.333B | 8.46 |
| Alpha Tau Medical (DRTS) | Israel | $0.302B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.292B | 0.00 |
| RxSight (RXST) | United States | $0.272B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.271B | 18.72 |
| Neuronetics (STIM) | United States | $0.259B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.76 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |